WO1999047001A1 - Increased bioavailability of lutein and zeaxanthin in humans and poultry using lysolecithin and lecithin - Google Patents
Increased bioavailability of lutein and zeaxanthin in humans and poultry using lysolecithin and lecithin Download PDFInfo
- Publication number
- WO1999047001A1 WO1999047001A1 PCT/US1999/005925 US9905925W WO9947001A1 WO 1999047001 A1 WO1999047001 A1 WO 1999047001A1 US 9905925 W US9905925 W US 9905925W WO 9947001 A1 WO9947001 A1 WO 9947001A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pigment
- lysolecithin
- feed
- ton
- lecithin
- Prior art date
Links
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 title claims abstract description 81
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 title claims abstract description 72
- 229960005375 lutein Drugs 0.000 title claims abstract description 60
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 title claims abstract description 59
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 title claims abstract description 59
- 239000000787 lecithin Substances 0.000 title claims abstract description 45
- 235000010445 lecithin Nutrition 0.000 title claims abstract description 45
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 title claims abstract description 43
- 229940067606 lecithin Drugs 0.000 title claims abstract description 43
- 235000012680 lutein Nutrition 0.000 title claims abstract description 32
- 239000001656 lutein Substances 0.000 title claims abstract description 32
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 title claims abstract description 32
- 244000144977 poultry Species 0.000 title claims abstract description 29
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 title claims abstract description 22
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 title claims abstract description 22
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 title claims abstract description 22
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 title claims abstract description 22
- 235000010930 zeaxanthin Nutrition 0.000 title claims abstract description 22
- 229940043269 zeaxanthin Drugs 0.000 title claims abstract description 22
- 239000001775 zeaxanthin Substances 0.000 title claims abstract description 22
- 238000000034 method Methods 0.000 claims abstract description 40
- 235000021466 carotenoid Nutrition 0.000 claims abstract description 38
- 150000001747 carotenoids Chemical class 0.000 claims abstract description 38
- 210000002969 egg yolk Anatomy 0.000 claims description 74
- 235000008210 xanthophylls Nutrition 0.000 claims description 44
- 239000000203 mixture Substances 0.000 claims description 25
- 235000013345 egg yolk Nutrition 0.000 claims description 23
- 239000004094 surface-active agent Substances 0.000 claims description 22
- 150000003735 xanthophylls Chemical class 0.000 claims description 17
- 230000008021 deposition Effects 0.000 claims description 10
- 240000000785 Tagetes erecta Species 0.000 claims description 6
- 235000012311 Tagetes erecta Nutrition 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 239000006052 feed supplement Substances 0.000 claims 5
- 238000010521 absorption reaction Methods 0.000 abstract description 8
- 239000000049 pigment Substances 0.000 description 119
- 238000011282 treatment Methods 0.000 description 53
- 235000013601 eggs Nutrition 0.000 description 42
- 235000005911 diet Nutrition 0.000 description 39
- 230000037213 diet Effects 0.000 description 37
- 239000007788 liquid Substances 0.000 description 34
- 239000000047 product Substances 0.000 description 23
- 235000013594 poultry meat Nutrition 0.000 description 22
- 241000271566 Aves Species 0.000 description 20
- 240000003864 Ulex europaeus Species 0.000 description 18
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 15
- 235000013734 beta-carotene Nutrition 0.000 description 15
- 239000011648 beta-carotene Substances 0.000 description 15
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 15
- 229960002747 betacarotene Drugs 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 230000019612 pigmentation Effects 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 13
- 238000003556 assay Methods 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 11
- 239000002285 corn oil Substances 0.000 description 11
- 235000005687 corn oil Nutrition 0.000 description 11
- 241000287828 Gallus gallus Species 0.000 description 10
- 235000013330 chicken meat Nutrition 0.000 description 10
- 235000009200 high fat diet Nutrition 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000002131 composite material Substances 0.000 description 7
- 239000013589 supplement Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 230000004456 color vision Effects 0.000 description 6
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 5
- 241000282412 Homo Species 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 230000001804 emulsifying effect Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 239000008347 soybean phospholipid Substances 0.000 description 5
- 102000002322 Egg Proteins Human genes 0.000 description 4
- 108010000912 Egg Proteins Proteins 0.000 description 4
- TWFZGCMQGLPBSX-UHFFFAOYSA-N carbendazim Chemical compound C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 230000002860 competitive effect Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 238000007127 saponification reaction Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 235000012424 soybean oil Nutrition 0.000 description 4
- 239000003549 soybean oil Substances 0.000 description 4
- 235000005881 Calendula officinalis Nutrition 0.000 description 3
- 102000003939 Membrane transport proteins Human genes 0.000 description 3
- 108090000301 Membrane transport proteins Proteins 0.000 description 3
- 239000000828 canola oil Substances 0.000 description 3
- 235000019519 canola oil Nutrition 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000002655 kraft paper Substances 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 235000015263 low fat diet Nutrition 0.000 description 3
- 125000002635 lutein group Chemical group 0.000 description 3
- 230000009061 membrane transport Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000005191 phase separation Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 125000000746 allylic group Chemical group 0.000 description 2
- 239000003674 animal food additive Substances 0.000 description 2
- 230000003466 anti-cipated effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000013065 commercial product Substances 0.000 description 2
- 235000020940 control diet Nutrition 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 235000004213 low-fat Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000693 micelle Substances 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 125000001095 phosphatidyl group Chemical group 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 238000009827 uniform distribution Methods 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 235000009430 Thespesia populnea Nutrition 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 241001660687 Xantho Species 0.000 description 1
- CWRILEGKIAOYKP-SSDOTTSWSA-M [(2r)-3-acetyloxy-2-hydroxypropyl] 2-aminoethyl phosphate Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCCN CWRILEGKIAOYKP-SSDOTTSWSA-M 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000007950 acidosis Effects 0.000 description 1
- 208000026545 acidosis disease Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000036982 action potential Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 210000003323 beak Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 125000001409 beta-carotene group Chemical group 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001721 carbon Chemical class 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 235000002864 food coloring agent Nutrition 0.000 description 1
- 239000000576 food coloring agent Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 210000000992 latebra Anatomy 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- NJTGANWAUPEOAX-UHFFFAOYSA-N molport-023-220-454 Chemical compound OCC(O)CO.OCC(O)CO NJTGANWAUPEOAX-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000001053 orange pigment Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000000485 pigmenting effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 150000003254 radicals Chemical group 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000010410 reperfusion Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/179—Colouring agents, e.g. pigmenting or dyeing agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/40—Colouring or decolouring of foods
- A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
- A23L5/43—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
- A23L5/44—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
Definitions
- the invention relates generally to the absorption of carotenoids and, more specifically, to increasing the absorption and bioavailability of lutein and zeaxanthin in humans and poultry by the use of lysolecithin and lecithin.
- Carotenoids have long been used as important food coloring agents
- xanthophylls are added to poultry feeds so that upon ingestion, the xanthophylls are deposited in the skin and egg yolks Chickens specifically absorb
- lutein and its structural isomer zeaxanthin impart a yellow color to the chicken and its eggs that is commercially desirable
- Carotenoids have been hypothesized to reduce the risk of certain types of cancers in humans through their action as anti-oxidants that quench singlet oxygen and other oxidizing species thereby terminating free radical chain reactions and limiting cellular oxidation damage.
- lutein is among the most common and is known to exhibit strong anti- oxidant capabilities. The structure of lutein is:
- Lysolecithins (lysophosphatidylcholine, lysophosphatidylethanolamine, etc.) have been shown to have a variety of biological actions, all centered around modification of cell membrane permeability. Such effects include increased transfer of both cations and larger molecules across cell membranes in cultured cell lines (Duan, J. and M.P. Moffat (1991) "Protective effects of D.L-carnitine against arrhythmias induced by lysophosphatidylcholine or reperfusion", Eur. J.
- lecithins are phosphatidyl digylcerides, by which is meant that one of the three hydroxyl groups of glycerol (propane- 1, 2, 3-triol) is occupied by a phosphate group, which in turn is attached to a polar alkyl amine. The remaining two hydroxyls of glycerin are occupied by long-chain fatty acids.
- N cH 3 ) 3 is:
- lecithin as a phosphatidyl diglyceride, has both a polar, charged end and a highly hydrophobic one - the prime requirements of an emulsifier.
- Removal of the fatty acid in the center position by phospholipase A produces lysolecithins whose chemical properties differ noticeably from those of lecithins due to the greater hydrophilicity of its polar end. It has been found that the fatty acid remaining on lysolecithin is generally unsaturated (Dawson, et al. , ( 1990) "Fatty acid composition fo the neutral lipid and phospholipid fractions of mechanically deboned chicken meat", Poultry Science, 64: 1411-1419.
- the invention consists of a method and compound for increasing the abso ⁇ tion and bioavailabihty of carotenoids in humans and poultry by the use of lysolecithin and lecithin
- a formulation is made comprising the addition of a surfactant, including either lysolecithin or lecithin or both, to a carotenoid, including either lutein or zeaxanthin or a mixture of both
- the range of surfactant to carotenoid is between about 5% and about 30% by weight
- the formulation is fed as a food supplement and results in an increased abso ⁇ tion and bioavailabihty of the carotenoids 5
- An object of the present invention is to provide a food supplement including a carotenoid which increases the abso ⁇ tion of the carotenoid by an animal or human that is fed the supplement.
- Another object of the invention is to provide a method for increasing the abso ⁇ tion and bioavailabihty of carotenoids in food supplements.
- Still another object of the invention is to provide a method of increasing the abso ⁇ tion and bioavailabihty of lutein and zeaxanthin extracted from marigold petals.
- Figure 1 is a graphical representation of the results of NEPA analysis of egg yolks to determine pigment uptake in chickens fed a variety of diets including control diets and diets supplemented with feed additives of the present invention.
- Figure 2 is a graphical representation of the L* a* b* Color Space Figure in the Operation Manual of the Minolta Chroma Meter ⁇ .
- Figure 3 is a graphical representation of the results of reflectance colorimetric analysis of egg yolks from chickens fed lysolecithin-treated and untreated poultry feed.
- Figures 4 and 5 are a graphical representations of the results of NEPA analysis of egg yolks to determine pigment uptake in chickens fed a variety of diets including control diets and diets supplemented with feed additives of the present invention.
- Figure 6 is a graphical representation of the emulsifying properties of lysolecithin and measures the retardation of the phase separation over time. 6
- Carotenoids particularly the xanthophylls lutein and zeaxanthin, are important as colorants in animal feeds, particularly poultry feeds.
- Commercially available sources of the xanthophylls include the products of Kemin Industries, Inc., that are extracts of marigold (Tagetes erecta) and sold under the marks ORO GLO ® Liquid and FloraGLO ® Lutein (20% Liquid).
- ORO GLO ® Liquid has 7 grams of xanthophyll activity per pound (as determined by a method condensed from the Association of Official Analytical Chemists, paragraph 43.108, and available from Kemin Industries, Inc., part no. 02205).
- FloraGLO ® Lutein (20% Liquid) has 20% lutein and 0.86% zeaxanthin.
- the sources of xanthophylls have been used as additives to animal feeds to inco ⁇ orate the pigments into the body tissues and products of the animals.
- a method and formulation for increasing the level of abso ⁇ tion and bioavailabihty of the carotenoids has been developed.
- a formulation containing lutein and zeaxanthin is combined with lecithin and with lysolecithin at a concentration of between about 5% to about 30% by weight.
- the lutein and zeaxanthin source is mixed with the source of lecithin or lysolecithin and the mixture is added to feed for the animal.
- the treated feed is fed to animals for a predetermined length of time and the body tissues and animal products were assayed for xanthophyll content.
- the treated feed is found to increase the amount of the xanthophylls inco ⁇ orated by the animal by between about 2% and about 50% over control feed that included the same amounts of xanthophylls but which had not been combined with lecithin or lysolecithin.
- a quantity of a liquid source of xanthophylls was blended with a liquid source of lecithin or lysolecithin at high speed for an extended period of time to thoroughly mix the ingredients.
- the mixture was added to a low xanthophyll feed in 7 a mixer to assure uniform distribution.
- a control feed was formulated using the same low xanthophyll feed to which was added the same quantity of the liquid xanthophyll source also in a mixer to assure uniform distribution.
- the treated feed and the control feed were fed to separate groups of chickens for approximately one-month. Eggs were collected from both groups and analyzed using the NEPA test for pigment content.
- the pigment content of the eggs showed an increased pigment content in chickens fed the treated diet that correspond to chickens that had been fed an untreated diet including up to 50% higher concentrations of xanthophylls.
- the abso ⁇ tion and bioavailabihty of the xanthophylls was increased by up to 50%.
- Experiment 1 A feeding trial was conducted over a 28 consecutive day period. The trial used two hundred and twenty- four white Leghorn Hyline W36 cross birds, 29 weeks of age at the start of the study. The birds were housed in battery pens of eight or nine birds. All birds were fed a low-pigment diet for 1 month immediately prior to the start of the trial. Composition of the low xanthophyll diet used in this study is shown in Table 1 . Each treatment was fed to three replicate pens holding either eight or nine birds. The remaining birds received control low xanthophyll feed. Egg production was monitored throughout the test and remaining test feed for each treatment was weighed to determine feed consumption.
- the source of xanthophylls used in the trial was ORO GLO Liquid having a measured pigment content of 5.2 g/lb xanthophyll activity.
- the source of lysolecithin used was Lysoprin-brand lysolecithin purchased from Lovesgrove Research (Aberystwyth, Wales), product no. 10544.
- Target application rates for ORO GLO and Lysoprin are shown in Table 2. For the treatments with Lysoprin, 0.78, 1.17 and 1.56 lb of ORO GLOliquid were added to 0.23 lb of Lysoprin. The mixture was blended at high speed in a Waring blender for 15 minutes.
- Each mixture was poured, during mixing, into a ribbon mixer containing 195 lbs of low xanthophyll feed which had 10 been previously treated with 150 ppm TERMOX ® dry (from Antitox, Buford, Georgia) and 1,000 ppm Myco CURB ® liquid (from Kemin Industries, Inc.).
- the diets thus produced contained the equivalent of 40, 60 and 80 grams of xanthophyll activity per ton of feed, respectively.
- Control feed was prepared by addition of 0.78, 1.17 and 1.56 lb of ORO GLO liquid directly to low xanthophyll feed without addition of Lysoprin. Samples of each feed were taken and analyzed for pigment content using a method based on AOAC, Paragraph 43.018, without saponification and column chromatography.
- treatment levels will be referred to by the target level of total xanthophyll activity in grams of xanthophyll per ton of feed as desc ⁇ bed in the Methods and Mate ⁇ als section and Table 2
- Egg collection data feed/bird/day and average egg weight
- NEPA National Egg Products Association which originally developed it In modified form, it has been accepted as a standard method by the AOAC (Journal of the
- colorimeter data is obtained and reported as the values L*, a* and b* which correspond to the position of the reflected color in a three-dimensional system.
- the L* value is a measure of brightness (luminosity) and a* and b* are chromaticity coordinates along green-red and yellow- blue axes, respectively.
- the coordinate system is shown graphically as Figure 2. While actual color changes can most accurately be presented on a three-dimensional graph, it is common practice to report the individual L*, a* and b* values.
- the L* a* b* system is designed to mimic human color perception.
- the relatively small changes in L*, a* and b* upon addition of pigment correlates well 15 with the known difficulty in perceiving color changes at the pigment levels used m this study Conside ⁇ ng the lack of hnea ⁇ ty of response within the CIE t ⁇ angle to yolk color changes, the high degree of lmea ⁇ ty in the a* value response for untreated feed ( Figure 3) with increasing pigment levels observed in this study should be noted
- the correlation coefficient (R 2 ) from untreated feed is 0 999, it is 0 973 from lysolecithm-treated feed
- the ORO GLO liquid used for the trial had a pigment content of 5.32 g/lb.
- Target application rates for ORO GLO, Lysoprin brand lysolecithin and bulk soy lecithin are shown in Table 6.
- For the treatments with Lysoprin and lecithin 55, 1 10 or 165 grams of either Lysoprin or lecithin were blended with 550 grams of ORO GLO liquid. The mixture was blended at high speed in a Waring blender for 7.5 minutes and at low speed for 5 minutes. The ORO GLO used in the control treatment was not blended.
- Treatment was affected by pouring each of the above pigment mixtures onto feed in a ribbon mixer containing 210 lbs of low xanthophyll feed which had been previously treated with 150 ppm TERMOX dry and 1,000 ppm MYCO CURB liquid.
- Control feed was prepared by addition of appropriate amounts of ORO GLO liquid, as outlined in Table 2, directly to low xanthophyll feed without addition of Lysoprin or lecithin.
- Each treated feed was run through a hammer mill and mill screen to aid in pigment distribution, then weighed in lots of 35 lbs into poly- lined Kraft bags. Samples of each feed were taken and analyzed for pigment content using a method based on AOAC, Paragraph 43.018, without saponification and column chromatography.
- Prin Lysoprin brand lysolecithin.
- BCE ⁇ Carotene Equivalents a-d Ent ⁇ es in column with no common supersc ⁇ pts differ significantly (P ⁇ 0 05)
- a feeding t ⁇ al was done for 28 days Two hundred and twenty-four white Leghorn Hyline W36 cross birds were used, 47 weeks of age at the start of the study 20
- House temperatures ranged from 58° to 72°
- the ORO GLO liquid used for the trial had a pigment content of 5.4 g/lb.
- Target application rates for ORO GLO, LYSOFORTE and Lysoprin lysolecithin supplements are shown in Table 9. Since LYSOFORTE is a 10% suspension of Lysoprin on an inert carrier, application rates for LYSOFORTE were set at 10 times those for Lysoprin. Thus, a 2.2 lb/ton treatment of LYSOFORTE is designed to parallel a 0.22 lb/ton application of Lysoprin.
- Lysoprin For the treatments with Lysoprin, 10.5, 42 and 105 grams of Lysoprin were blended with 352 grams of ORO GLO liquid. The mixture was blended at high speed in a Waring blender for 15 minutes. Treatment was affected by pouring each of the above pigment mixtures onto feed in a ribbon mixer containing 210 lbs of low xanthophyll feed which had been previously treated with 150 ppm TERMOX dry and 1 ,000 ppm MYCO CURB liquid. LYSOFORTE treatments were prepared by adding 105 and 420 grams of LYSOFORTE ( 10% Lysoprin) to the mixer after adding pigment.
- Control feed was prepared by addition of appropriate amounts of ORO GLO liquid, as outlined in Table 2, directly to low xanthophyll feed without addition of Lysoprin or LYSOFORTE. Samples of each feed were taken and analyzed for pigment content using a method based on AOAC, Paragraph 43.018, without saponification and column chromatography. 21
- Inco ⁇ oration of Lysoprin lysolecithin into pigment-supplemented poultry diets for active layers yields statistically valid increases in the pigment content of egg yolks. Based on the above data, a pigment level of 40 g ORO GLO liquid/ton of feed, with addition of lysolecithin at the application rates used in this study, will show yolk color performance between that of 40 g/ton and 60 g/ton untreated feeds. Conversely, addition of LYSOFORTE dry lysolecithin supplement did not improve pigment inco ⁇ oration.
- the experimental diets were prepared in the following manner. Five samples of 210 lbs of the low-xanthophyll diet of Table 1 were supplemented with one of the following: 2.2 lbs/ton of Lysoprin , an alternative commercial product (Blendmax 322D liquid), 11 lbs/ton LYSOFORTE, and an untreated control. In addition each sample was treated with 8 lbs/ton ORO GLO® brand liquid and 2 lbs/ton MYCO CURB® brand liquid. The liquid lysolecithin products were mixed with the ORO GLO liquid in a Waring Blender for one minute before treating the feed.
- the lysolecithin and/or pigment products were added to the feed at the indicated levels by slowly pouring the additive onto feed during mixing in a ribbon mixer. After running through a hammer mill with a mill screen, 35 lbs of each treatment was weighed into poly-lined Kraft bags. 25
- the quality assurance test were carried out in the following manner. 1.6 g of liquid Lysoprin and 8 g of dry LYSOFORTE are added to separate 100 ml samples of canola oil. These solutions were then mixed thoroughly, after which the dry LYSOFORTE was filtered to remove all carrier material. At the same time a 15% NaCl solution was prepared. Fifty ml of the lysolecithin solutions and 50 ml of the 15% NaCl solution were added to a 150 ml beaker. The materials were mixed with a 10,000 rpm bio-homogenizer for 15 seconds. The emulsion was immediately transferred to a 100 ml graduated cylinder. The volume of the lower phase (the free 15% NaCl solution) of the emulsion was observed at time 0 and then every five minutes over a 60 minute period. A blank of canola oil and the 15% NaCl was also run for comparison.
- the yolk fan scores were conducted first. Ten grams of the composite egg yolk material from each treatment was placed in a plastic 60 x 15 mm Falcon 1007 petri dish. Six individuals in the research facility were then asked to determine the color fan score of each yolk composite. The fan scores were then analyzed at the 95% confidence level using Duncan's multiple comparison procedure (Statgraphics Plus, Manugistics, Inc., 1995).
- the intensity (L), red (a), and yellow (b) pigmentation was measured using a CR-300 Minolta Colorimeter. Again, 10 g of the composites egg yolk from each treatment was placed in a plastic 60 x 15 mm Falcon 1007 petri dish. To measure the L*a*b of each treatment the sample was placed on the top of the measuring head with 26 an open o ⁇ fice for color head Measurements of L*a*b were replicated twice for each sample The L, a and b scores were then analyzed at the 95% confidence level using Duncan's multiple comparison procedure
- Lysoprin (lot 200795) 80.61 80.48 80.54 e 15.6
- Lysoprin (lot 250795) 74.06 73.12 73.59° 5.6
- the results of this trial also indicate that there is a positive, although limited, correlation between the results of the quick assay and the results of the layer trial.
- the three liquid Lysoprin lots that performed well in the layer trial also performed well in the quick assay while the dry LYSOFORTE product failed in both, the quick assay as well as the layer trial.
- the quick assay failed to predict the order of performance that was seen in the layer trial (e.g., Blendmax 322D performed best in the quick assay but was inferior in the trial).
- Blendmax 322D performed best in the quick assay but was inferior in the trial.
- the emulsifying properties of the lysolecithin products are consistently seen only in canola oil, not however in corn oil or mineral oil.
- the Blendmax 322D product showed a good effect also in mineral oil. 29 Experiment 5
- Temperature in the house during the trial ranged from 20° C to 32° C.
- MYCO CURB® brand liquid was also added to each treatment at 0.916 kg/ton. Mixing of the feed samples was done in a ribbon mixer at low speed. Each treatment was weighed into poly-lined Kraft bags, after running through a hammer 30 mill with a mill screen Samples were taken and analyzed for pigment content using QC method QPM-10 without saponification or chromatography
- Pigment conversion (%) 100% x (BCE) x (yolk weight) x feggs/da /hen) (Pigment) x (feed/hen/day)
- Tables 16 displays the results of the quantitative determination of the pigments and pigment conversion in the egg yolks Addition of ORO GLO to the low pigment
- the diet resulted m a 35 0% better pigment conversion as compared to the low pigment diet
- lecithin or Lysop ⁇ n up to a final concentration of 0 916 kg/ton feed were added with the ORO GLO dry to the low fat or the high fat diet
- lecithin showed the greatest increase in pigmentation and pigment conversion (22.2% over the ORO GLO control) for the low fat diet
- Lysoprin resulted in the best increase for the high fat diet (23.3% over the ORO GLO/high fat control).
- surfactant treatments of the low fat diet were not statistically different among each other.
- the egg productivity of the laying hens was also monitored for the duration of the trial. The results are displayed in Table 17. No significant differences in egg productivity were seen for the various treatments.
- a high fat diet was observed to lead to higher pigment utilization and pigment conversion as compared to a low or no fat diet. It further appears that while lecithin performs better in a low fat diet, Lysoprin performs better in a high fat diet as measured by pigment conversion.
- the first observation can be explained reasonably by the fact that uptake by the bird and deposition of the hydrophobic carotenoid molecules in the egg yolk is more effective when dispersed in fat in the animal's gut.
- the second observation seems to reflect a more specific effect with much higher efficacy for the lecithin and Lysoprin as compared to the soybean oil/poultry fat blend.
- Lysoprin can display full efficacy as an emulsifying agent only in a diet supplemented with a certain amount of fat.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Birds (AREA)
- Mycology (AREA)
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
- General Preparation And Processing Of Foods (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU30988/99A AU745973B2 (en) | 1998-03-18 | 1999-03-17 | Increased bioavailability of lutein and zeaxanthin in humans and poultry using lysolecithin and lecithin |
BR9908891-6A BR9908891A (en) | 1998-03-18 | 1999-03-17 | Processes to increase the absorption and bioavailability of carotenoids in humans and poultry, to increase the deposition of carotenoids in poultry tissues and egg yolks, and to increase the deposition of carotenoids in tissues, including blood and the macular region of the retina , from humans, and, food supplement to increase the absorption and bioavailability of carotenoids in humans and poultry |
MXPA00009116A MXPA00009116A (en) | 1998-03-18 | 1999-03-17 | Increased bioavailability of lutein and zeaxanthin in humans and poultry using lysolecithin and lecithin. |
EP99912665A EP1063898A4 (en) | 1998-03-18 | 1999-03-17 | Increased bioavailability of lutein and zeaxanthin in humans and poultry using lysolecithin and lecithin |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7847598P | 1998-03-18 | 1998-03-18 | |
US60/078,475 | 1998-03-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999047001A1 true WO1999047001A1 (en) | 1999-09-23 |
Family
ID=22144258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/005925 WO1999047001A1 (en) | 1998-03-18 | 1999-03-17 | Increased bioavailability of lutein and zeaxanthin in humans and poultry using lysolecithin and lecithin |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1063898A4 (en) |
AU (1) | AU745973B2 (en) |
BR (1) | BR9908891A (en) |
MX (1) | MXPA00009116A (en) |
WO (1) | WO1999047001A1 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6462033B2 (en) | 2000-07-26 | 2002-10-08 | Alcon Universal Ltd. | Process for manufacturing compositions containing ciprofloxacin and hydrocortisone |
WO2008020747A1 (en) | 2006-08-18 | 2008-02-21 | Industrial Organica S.A. De C.V. | A method for obtaining stable micro-emulsions of derivatives of oxycarotenoids of short-chain organic acids, micro-emulsions obtained, and formulation which contains these |
WO2008029909A1 (en) * | 2006-09-08 | 2008-03-13 | Kaneka Corporation | Composition comprising reduced coenzyme q10 and lysolecithin |
EP2468111A1 (en) | 2010-12-21 | 2012-06-27 | Jose-Odon Torres-Quiroga | Compositions and applications of carotenoids of improved absorption and bioavailability |
WO2013060577A1 (en) * | 2011-10-25 | 2013-05-02 | Unilever N.V. | Edible product and use thereof for increasing bioavailability of micronutrients comprised in vegetables or fruit |
US20130216512A1 (en) * | 2002-01-03 | 2013-08-22 | Christopher J. Milley | Stable aqueous suspension |
EP2700320A4 (en) * | 2011-02-23 | 2017-06-28 | JX Nippon Oil & Energy Corporation | Zeaxanthin-enriched poultry egg |
US20220023249A1 (en) * | 2020-07-21 | 2022-01-27 | Industrial Organica, SA de CV | Carotenoid Formulation For Increased Bioavailability |
JP2022551827A (en) * | 2019-10-15 | 2022-12-14 | オムニアクティブ ヘルス テクノロジーズ リミテッド | Xanthophyll compositions containing lutein and zeaxanthin with enhanced bioavailability |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7758884B2 (en) | 2005-01-28 | 2010-07-20 | Kemin Industries, Inc. | Formulation for increasing the deposition of dietary carotenoids in eggs |
DE102017009186A1 (en) | 2017-09-25 | 2019-03-28 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Lutein and derivatives containing composition and process for the preparation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06197703A (en) * | 1991-05-23 | 1994-07-19 | Ajinomoto Takara Corp:Kk | Feed additive for livestock |
DE19609538A1 (en) * | 1996-03-11 | 1997-09-18 | Basf Ag | Finely divided carotenoid and retinoid suspensions and process for their preparation |
EP0831797B1 (en) * | 1995-06-07 | 2007-03-07 | The Howard Foundation | Pharmaceutically active carotenoids |
-
1999
- 1999-03-17 BR BR9908891-6A patent/BR9908891A/en not_active IP Right Cessation
- 1999-03-17 EP EP99912665A patent/EP1063898A4/en not_active Withdrawn
- 1999-03-17 WO PCT/US1999/005925 patent/WO1999047001A1/en not_active Application Discontinuation
- 1999-03-17 AU AU30988/99A patent/AU745973B2/en not_active Ceased
- 1999-03-17 MX MXPA00009116A patent/MXPA00009116A/en not_active Application Discontinuation
Non-Patent Citations (3)
Title |
---|
CHEMICAL ABSTRACTS, 1 January 1900, Columbus, Ohio, US; abstract no. 121-279625, XP002919061 * |
CHEMICAL ABSTRACTS, 1 January 1900, Columbus, Ohio, US; abstract no. 121-56421, XP002919062 * |
See also references of EP1063898A4 * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6462033B2 (en) | 2000-07-26 | 2002-10-08 | Alcon Universal Ltd. | Process for manufacturing compositions containing ciprofloxacin and hydrocortisone |
US20130216512A1 (en) * | 2002-01-03 | 2013-08-22 | Christopher J. Milley | Stable aqueous suspension |
WO2008020747A1 (en) | 2006-08-18 | 2008-02-21 | Industrial Organica S.A. De C.V. | A method for obtaining stable micro-emulsions of derivatives of oxycarotenoids of short-chain organic acids, micro-emulsions obtained, and formulation which contains these |
US7435846B2 (en) | 2006-08-18 | 2008-10-14 | Industrial Organica, S.A. De C.V. | Absorption and bioavailability of carotenoids, formulations and applications |
WO2008029909A1 (en) * | 2006-09-08 | 2008-03-13 | Kaneka Corporation | Composition comprising reduced coenzyme q10 and lysolecithin |
JP5286086B2 (en) * | 2006-09-08 | 2013-09-11 | 株式会社カネカ | Composition containing reduced coenzyme Q10 and lysolecithin |
EP2468111A1 (en) | 2010-12-21 | 2012-06-27 | Jose-Odon Torres-Quiroga | Compositions and applications of carotenoids of improved absorption and bioavailability |
EP2700320A4 (en) * | 2011-02-23 | 2017-06-28 | JX Nippon Oil & Energy Corporation | Zeaxanthin-enriched poultry egg |
WO2013060577A1 (en) * | 2011-10-25 | 2013-05-02 | Unilever N.V. | Edible product and use thereof for increasing bioavailability of micronutrients comprised in vegetables or fruit |
JP2022551827A (en) * | 2019-10-15 | 2022-12-14 | オムニアクティブ ヘルス テクノロジーズ リミテッド | Xanthophyll compositions containing lutein and zeaxanthin with enhanced bioavailability |
EP4045019A4 (en) * | 2019-10-15 | 2023-11-29 | Omniactive Health Technologies Limited | Xanthophyll composition comprising lutein and zeaxanthin with enhanced bioavailability |
US20220023249A1 (en) * | 2020-07-21 | 2022-01-27 | Industrial Organica, SA de CV | Carotenoid Formulation For Increased Bioavailability |
Also Published As
Publication number | Publication date |
---|---|
MXPA00009116A (en) | 2003-07-28 |
BR9908891A (en) | 2001-10-02 |
AU745973B2 (en) | 2002-04-11 |
AU3098899A (en) | 1999-10-11 |
EP1063898A4 (en) | 2003-06-04 |
EP1063898A1 (en) | 2001-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pérez-Vendrell et al. | Influence of source and ratio of xanthophyll pigments on broiler chicken pigmentation and performance | |
Skřivan et al. | Increase in lutein and zeaxanthin content in the eggs of hens fed marigold flower extract. | |
Marounek et al. | Use of carotenoids in feed mixtures for poultry: a review | |
Castañeda et al. | Skin pigmentation evaluation in broilers fed natural and synthetic pigments | |
Lokaewmanee et al. | Enhancement of yolk color in raw and boiled egg yolk with lutein from marigold flower meal and marigold flower extract | |
Díaz-Gómez et al. | High-carotenoid biofortified maize is an alternative to color additives in poultry feed | |
AU745973B2 (en) | Increased bioavailability of lutein and zeaxanthin in humans and poultry using lysolecithin and lecithin | |
Jang et al. | Effects of dietary lutein sources on lutein-enriched egg production and hepatic antioxidant system in laying hens | |
Sünder et al. | Egg yolk colour in organic production as affected by feeding–Consequences for farmers and consumers | |
Marusich et al. | Oxycarotenoids in poultry pigmentation: 1. Yolk studies | |
Lokaewmanee et al. | Effects of dietary mulberry leaves (Morus alba L.) on egg yolk color | |
Islam et al. | Lutein specific relationships among some spectrophotometric and colorimetric parameters of chicken egg yolk | |
Tunio et al. | Effect of pigments with different origins on pigmentation and performance of broilers | |
US5997922A (en) | Broiler skin and egg yolk pigmentation by using saponified marigold extracts with a high content of zeaxanthin | |
Sünder et al. | Influence of high vitamin E dosages on retinol and carotinoid concentration in body tissues and eggs of laying hens | |
AU780958B2 (en) | Carotenoid esters | |
MXPA96006679A (en) | Extract and formulation for the pigmentation of lapiel de pollo and egg yem and method parasu administrac | |
Middendorf et al. | Variation in the biological availability of xanthophyll within and among generic sources | |
Hinton et al. | Subjective and colorimetric evaluation of the xanthophyll utilization of natural and synthetic pigments in broiler diets | |
Shahsavari | Influence of different sources of natural pigmenting on egg quality and performance of laying hens | |
Marusich et al. | Oxycarotenoids in Poultry Pigmentation: 2. Broiler Studies | |
Roncarati et al. | Effects of dietary supplementation with krill meal on pigmentation and quality of flesh of rainbow trout (Oncorhynchus mykiss) | |
Skřivanová et al. | Effect of the source and level of carotenoids in diets on their retention in eggs. | |
Breithaupt | Xanthophylls in poultry feeding | |
Seemann | Factors which influence pigmentation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BA BG BR CA CN CZ EE GE HR HU ID IL IS JP KP KR LT LV MK MX NZ PL RO RU SG SI SK TR UA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2000/009116 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 30988/99 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999912665 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999912665 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 30988/99 Country of ref document: AU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999912665 Country of ref document: EP |